Risk assessment for cancer-associated thrombosis: what is the best approach?
about
Biomolecular markers of cancer-associated thromboembolismVenous thromboembolism (VTE) and glioblastoma.The role of platelets in tumour growth.Proteomic analysis of venous thromboembolism: an update.Patient selection for thromboprophylaxis in medical inpatients.Incidence of venous thromboembolism (VTE) in ambulatory pancreatic cancer patients receiving chemotherapy and analysis of Khorana's predictive model.Low-molecular-weight heparins for the prevention of recurrent venous thromboembolism in patients with cancer: A systematic literature review of efficacy and cost-effectiveness.Thromboembolic disease in patients with high-grade glioma.Predictive factors of thromboembolic complications in patients with esophagogatric adenocarcinoma undergoing preoperative chemotherapy.ADAMTS-13 and von Willebrand factor predict venous thromboembolism in patients with cancer.Association of Peripheral Monocyte Count with Soluble P-Selectin and Advanced Stages in Nasopharyngeal Carcinoma.Mecanismos do tromboembolismo venoso no câncer: uma revisão da literatura.
P2860
Q26865716-A52E6D31-9B6E-480B-9796-ED027668D39AQ33422929-1FDE21EB-9934-4831-9CF4-504688EAF28CQ33803558-90C879E5-8F0F-4F33-89B0-4FE2C301A29AQ38097846-93CF937D-F055-4A02-8835-7D2251A69609Q38161521-4AF323EC-C9F8-485A-9A6E-B8ABFB4F2128Q38197110-B232A6E2-EF01-4E57-AC50-3E87491F777AQ38600392-4CB6F133-F688-4908-A8B4-33606C7EFAC9Q42407190-1180F412-2B06-4D3A-A1F2-F50ABA4AA139Q47194813-B2615E6F-B3FF-44A9-9586-C3CF8793E84AQ53275633-69F1FED8-0992-44D2-B374-D87FE206BA41Q55255652-5935F7F6-4C8D-4D2C-A7D3-61F84AFE3ED5Q55432473-2EF61806-9363-474B-AC97-22FF66BE3B25
P2860
Risk assessment for cancer-associated thrombosis: what is the best approach?
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Risk assessment for cancer-associated thrombosis: what is the best approach?
@en
type
label
Risk assessment for cancer-associated thrombosis: what is the best approach?
@en
prefLabel
Risk assessment for cancer-associated thrombosis: what is the best approach?
@en
P1433
P1476
Risk assessment for cancer-associated thrombosis: what is the best approach?
@en
P2093
Alok A Khorana
P356
10.1016/S0049-3848(12)70009-9
P478
129 Suppl 1
P577
2012-04-01T00:00:00Z